EN
HI
Summary
As of 5 Oct, 2026, Morepen Laboratories stock price is ₹134.4. During the trading session, the stock has moved between an intraday low of ₹130.46 and an intraday high of ₹137.64. Over the last 52 weeks, Morepen Laboratories has traded between ₹33.05 and ₹137.64.
The stock has recorded a trading volume of 1,61,72,184 shares,. Its Average Traded Price (ATP) is ₹133.69, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 52 @ ₹134.40.
Morepen Laboratories has an upper circuit limit of ₹147.09 and a lower circuit limit of ₹120.35. The total value traded stands at ₹216.21 CR, and the delivery percentage for the day is 20.48%.
The stock is currently traded with a market lot size of 1. Morepen Laboratories also offers a dividend yield of 0.15%.
Morepen Laboratories Share Price Chart
Morepen Laboratories Share Key Metrics
Volume
1.62 CR
Market Cap
7327.24 CR
LTQ@LTP
52@134.40
ATP
133.69
Var Margin
100 %
Circuit Range
120.35-147.09
Delivery %
20.48 %
Value
216.21 CR
ASM/GSM
No
Market Lot
1
Morepen Laboratories Fundamentals
P/E Ratio
52.13
P/B Ratio
5.62
Div. Yield
0.15
Sector P/E
42.73
Sector P/B
3.55
Sec. Div. Yield
0.52
Morepen Laboratories Resistance and Support
Pivot 131.39
Resistance
First Resistance
137.62
Second Resistance
141.52
Third Resistance
147.75
Support
First Support
127.49
Second Support
121.26
Third Support
117.36
Morepen Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Oct 05 2026 | 134.5 | 134.4 | 0.51% | 137.64 | 130.46 |
| Thu Oct 01 2026 | 125.9 | 133.72 | 6.14% | 135.28 | 125.16 |
| Wed Sep 30 2026 | 119.33 | 125.98 | 6.04% | 128.1 | 117.8 |
Morepen Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-04 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-05-22 | Audited Results |
| 2026-02-10 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-06 | Quarterly Results & Others |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Morepen Laboratories News
Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Morepen Laboratories submitted its first Abbreviated New Drug Application (ANDA) to the U.S. FDA for Sitagliptin Tablets USP. This strengthens the company's integrated CDMO capabilities and expands its finished dosage development into regulated markets.
Sep 28 2026 08:53:27
Morepen Laboratories Ltd - 500288 - Intimation Regarding ESG Rating
Morepen Laboratories received an 'Adequate' ESG rating of 'CRISIL ESG 60' from Crisil ESG Ratings & Analytics Limited. This independent assessment for fiscal 2026 was based on publicly available information.
Sep 22 2026 16:10:43
Morepen Laboratories Management
| Name | Position |
|---|---|
| Sushil Suri | Chairman & Managing Director |
| Sanjay Suri | Whole Time Director |
Morepen Laboratories Similar Stocks
Symbiotec Pharmalab Ltd.
1167.50
-30.50 (2.55%)
Innova Captab Ltd.
1145.80
-22.20 (1.90%)
Sanofi India Ltd.
3021.90
-15.50 (0.51%)
Nephrocare Health Services Ltd.
638.50
-10.45 (1.61%)
Kovai Medical Center & Hospital Ltd.
5973.00
-20.50 (0.34%)
Senores Pharmaceuticals Ltd.
1325.00
-24.60 (1.82%)
Orchid Pharma Ltd.
966.15
-23.85 (2.41%)
IOL Chemicals And Pharmaceuticals Ltd.
206.89
-2.50 (1.19%)
Artemis Medicare Services Ltd.
324.50
-11.90 (3.54%)
FDC Ltd.
333.65
-2.25 (0.67%)
Morepen Laboratories FAQs
The Buying Price of Morepen Laboratories share is 134.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Morepen Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Morepen Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Morepen Laboratories shares is 52.13. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Morepen Laboratories shares is 5.62. Useful to assess the stock's value relative to its book value.
To assess Morepen Laboratories’s valuation compare Sector P/E, P/B which are 42.73 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Morepen Laboratories is 7327.24 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Morepen Laboratories share price is 137.64 & 33.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Morepen Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in MOREPENLAB
Or Download Choice FinX App
Invest in MOREPENLAB
